LYMPHOMA LEUKAEMIA MYELOMA FUND (WALES)
Fund raising to promote the work of the Haematology unit at Swansea NHS Trust, and related institutions in Wales, in the support of patients and their families diagnosed with blood cancer diseases e.g. Lymphoma, Leukaemia and Multiple Myeloma. This includes the purchase of equipment not normally provided by the NHS. Also to promote research and disseminate information related to blood cancer.
Financial health, per its FY2025 accounts
The accounts state that the charity holds unrestricted reserves of £314,367, which is significantly above the trustees' stated ideal target of £30,000. The trustees consider the charity to be a going concern, supported by these significant reserves over budget costs. The charity reported a net surplus for the year, having no paid staff and relying on volunteers.
What the accounts disclose
“The trustees’ consider that the ideal level of reserves as at 28 February 2025 would be £30,000.”
Funders the charity credits
- Swansea Council
Trustees
- Karen Shreevechair
- Andrew Chilcott
- Jonathan Christopher Hughes
- Melanie Thomas
- Susan Thomas
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 28/02/2025 | £49k | £53k |
| 29/02/2024 | £35k | £9k |
| 28/02/2023 | £16k | £1k |
| 28/02/2022 | £22k | £2k |
| 28/02/2021 | £19k | £5k |
Common questions
Is LYMPHOMA LEUKAEMIA MYELOMA FUND (WALES) financially healthy?
Per its FY2025 accounts: The accounts state that the charity holds unrestricted reserves of £314,367, which is significantly above the trustees' stated ideal target of £30,000. The trustees consider the charity to be a going concern, supported by these significant reserves over budget costs. The charity reported a net surplus for the year, having no paid staff and relying on volunteers. Its FY2025 accounts were independently examined.